Yun Li’s Posts

Now that Trump can safely turn his attention back to policymaking, some stocks could get a boost from his agenda and new GOP prospects in 2020.

Shares of Biogen plummeted Thursday after the company halted the trial of Alzheimer’s disease drug aducanumab.

Boeing said a software change is in the works and Bank of America estimated it would take Boeing three to six months to “certify the fix.”

Cheaply priced stocks are getting cheaper as expensive stocks have gotten extremely pricey, pushing the valuation gap to the widest in 70 years, according to AB Bernstein.

The trade deal U.S. negotiators are seeking will have some teeth in case China goes back on its trade promises, The New York Times reported.